Gene Symbol | Gene ID | Gene Info |
---|---|---|
NR1H4
|
ENSG00000012504.9 | nuclear receptor subfamily 1 group H member 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_100878368_100878519 | NR1H4 | 10710 | 0.239567 | 0.48 | 1.9e-01 | Click! |
chr12_100878057_100878208 | NR1H4 | 10399 | 0.240377 | 0.16 | 6.8e-01 | Click! |
chr12_100841558_100841709 | NR1H4 | 25853 | 0.185459 | -0.08 | 8.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr20_56039749_56039992 | 4.45 |
CTCFL |
CCCTC-binding factor (zinc finger protein)-like |
59443 |
0.1 |
chr17_72787457_72787723 | 1.31 |
TMEM104 |
transmembrane protein 104 |
14931 |
0.1 |
chr9_92083234_92083501 | 1.24 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
11438 |
0.23 |
chr19_5952060_5952229 | 1.11 |
RANBP3 |
RAN binding protein 3 |
25946 |
0.08 |
chr7_156715297_156715479 | 1.00 |
NOM1 |
nucleolar protein with MIF4G domain 1 |
27029 |
0.15 |
chr10_30995761_30995912 | 0.99 |
SVILP1 |
supervillin pseudogene 1 |
10986 |
0.26 |
chr15_89200326_89200502 | 0.93 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
18230 |
0.16 |
chr19_16677483_16677695 | 0.92 |
CTD-3222D19.10 |
|
1227 |
0.26 |
chr19_42382114_42382373 | 0.92 |
CD79A |
CD79a molecule, immunoglobulin-associated alpha |
868 |
0.44 |
chr14_91855068_91855898 | 0.91 |
CCDC88C |
coiled-coil domain containing 88C |
28207 |
0.19 |
chr3_16326802_16326964 | 0.91 |
OXNAD1 |
oxidoreductase NAD-binding domain containing 1 |
16135 |
0.16 |
chr1_28318555_28318747 | 0.90 |
RP11-460I13.2 |
|
31947 |
0.1 |
chr7_100147991_100148484 | 0.89 |
AGFG2 |
ArfGAP with FG repeats 2 |
5053 |
0.1 |
chr14_21492164_21492434 | 0.89 |
NDRG2 |
NDRG family member 2 |
44 |
0.94 |
chr4_100739674_100739989 | 0.89 |
DAPP1 |
dual adaptor of phosphotyrosine and 3-phosphoinositides |
1828 |
0.43 |
chr4_2815730_2815905 | 0.88 |
SH3BP2 |
SH3-domain binding protein 2 |
1786 |
0.37 |
chr9_95791042_95791245 | 0.86 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
13801 |
0.18 |
chr22_24039705_24040048 | 0.86 |
RGL4 |
ral guanine nucleotide dissociation stimulator-like 4 |
1205 |
0.35 |
chr6_110796846_110797132 | 0.83 |
SLC22A16 |
solute carrier family 22 (organic cation/carnitine transporter), member 16 |
610 |
0.69 |
chr14_96830281_96830470 | 0.80 |
ATG2B |
autophagy related 2B |
168 |
0.79 |
chr3_32376993_32377254 | 0.79 |
CMTM7 |
CKLF-like MARVEL transmembrane domain containing 7 |
56040 |
0.12 |
chr11_1876820_1877006 | 0.78 |
LSP1 |
lymphocyte-specific protein 1 |
2713 |
0.14 |
chr16_21658961_21659187 | 0.78 |
IGSF6 |
immunoglobulin superfamily, member 6 |
4853 |
0.13 |
chr17_25622305_25622549 | 0.78 |
WSB1 |
WD repeat and SOCS box containing 1 |
1055 |
0.47 |
chr2_97627578_97627763 | 0.78 |
ENSG00000252845 |
. |
5118 |
0.16 |
chr19_55009048_55009414 | 0.77 |
LAIR2 |
leukocyte-associated immunoglobulin-like receptor 2 |
131 |
0.93 |
chr11_60793314_60793556 | 0.77 |
CD6 |
CD6 molecule |
17429 |
0.14 |
chr11_67173408_67173659 | 0.77 |
TBC1D10C |
TBC1 domain family, member 10C |
1873 |
0.13 |
chr17_72674371_72674771 | 0.76 |
CTD-2006K23.2 |
|
832 |
0.49 |
chr1_20015023_20015174 | 0.75 |
HTR6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
23318 |
0.16 |
chr16_30461939_30462216 | 0.75 |
ENSG00000202476 |
. |
3341 |
0.08 |
chr10_73514245_73514396 | 0.74 |
C10orf54 |
chromosome 10 open reading frame 54 |
3067 |
0.26 |
chr7_148325963_148326351 | 0.72 |
C7orf33 |
chromosome 7 open reading frame 33 |
38500 |
0.16 |
chr2_68979555_68979777 | 0.71 |
ARHGAP25 |
Rho GTPase activating protein 25 |
17652 |
0.23 |
chr7_50309220_50309371 | 0.69 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
35029 |
0.21 |
chr9_117752150_117752475 | 0.69 |
TNFSF8 |
tumor necrosis factor (ligand) superfamily, member 8 |
59615 |
0.13 |
chr11_73688013_73688255 | 0.68 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
83 |
0.96 |
chr1_111738933_111739395 | 0.68 |
DENND2D |
DENN/MADD domain containing 2D |
4147 |
0.14 |
chr3_111032298_111032588 | 0.67 |
CD96 |
CD96 molecule |
20877 |
0.27 |
chrX_133961365_133961516 | 0.67 |
FAM122C |
family with sequence similarity 122C |
20173 |
0.16 |
chr14_106691102_106691449 | 0.66 |
IGHV3-21 |
immunoglobulin heavy variable 3-21 |
928 |
0.23 |
chr8_21436069_21436236 | 0.66 |
ENSG00000266630 |
. |
28643 |
0.23 |
chr3_195516005_195516156 | 0.65 |
MUC4 |
mucin 4, cell surface associated |
22648 |
0.17 |
chr3_16880178_16880359 | 0.65 |
PLCL2 |
phospholipase C-like 2 |
46184 |
0.18 |
chr11_67042731_67042882 | 0.65 |
ADRBK1 |
adrenergic, beta, receptor kinase 1 |
8854 |
0.11 |
chr7_150725797_150726152 | 0.65 |
ABCB8 |
ATP-binding cassette, sub-family B (MDR/TAP), member 8 |
420 |
0.58 |
chr14_22978569_22978851 | 0.64 |
TRAJ15 |
T cell receptor alpha joining 15 |
19870 |
0.09 |
chr16_9229875_9230060 | 0.64 |
RP11-473I1.10 |
|
28869 |
0.14 |
chr1_23858474_23858728 | 0.63 |
E2F2 |
E2F transcription factor 2 |
889 |
0.58 |
chr2_29236792_29237319 | 0.63 |
FAM179A |
family with sequence similarity 179, member A |
4072 |
0.19 |
chr1_114483922_114484073 | 0.63 |
HIPK1 |
homeodomain interacting protein kinase 1 |
9770 |
0.13 |
chr17_15490936_15491230 | 0.63 |
CDRT1 |
CMT1A duplicated region transcript 1 |
5639 |
0.14 |
chr1_147118412_147118650 | 0.63 |
ACP6 |
acid phosphatase 6, lysophosphatidic |
12585 |
0.22 |
chr18_2968689_2969110 | 0.62 |
RP11-737O24.1 |
|
1883 |
0.28 |
chr4_39974923_39975074 | 0.61 |
PDS5A |
PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae) |
4578 |
0.24 |
chr14_75173644_75173816 | 0.61 |
ENSG00000222604 |
. |
4924 |
0.14 |
chr10_112483545_112483823 | 0.61 |
ENSG00000252036 |
. |
32530 |
0.14 |
chr1_9789105_9789546 | 0.60 |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
11198 |
0.17 |
chr1_226917633_226918259 | 0.60 |
ITPKB |
inositol-trisphosphate 3-kinase B |
7213 |
0.24 |
chr5_98362452_98362659 | 0.60 |
ENSG00000200351 |
. |
90104 |
0.09 |
chr17_46514062_46514320 | 0.60 |
SKAP1 |
src kinase associated phosphoprotein 1 |
6610 |
0.15 |
chr9_92054735_92055023 | 0.60 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
3481 |
0.31 |
chr2_233973156_233973633 | 0.59 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
48205 |
0.13 |
chr5_156704413_156704690 | 0.59 |
CYFIP2 |
cytoplasmic FMR1 interacting protein 2 |
7821 |
0.15 |
chr9_515997_516400 | 0.59 |
ENSG00000264949 |
. |
8645 |
0.14 |
chr6_24867385_24867536 | 0.59 |
FAM65B |
family with sequence similarity 65, member B |
10081 |
0.19 |
chr19_54880893_54881262 | 0.58 |
LAIR1 |
leukocyte-associated immunoglobulin-like receptor 1 |
981 |
0.39 |
chr11_7552437_7552588 | 0.57 |
PPFIBP2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
6996 |
0.19 |
chr17_78682799_78682950 | 0.57 |
RP11-28G8.1 |
|
96558 |
0.07 |
chr8_134074351_134074605 | 0.57 |
SLA |
Src-like-adaptor |
1875 |
0.43 |
chr10_112033900_112034112 | 0.56 |
SMNDC1 |
survival motor neuron domain containing 1 |
30449 |
0.18 |
chr8_27242274_27242551 | 0.56 |
PTK2B |
protein tyrosine kinase 2 beta |
4244 |
0.27 |
chr16_11325836_11325987 | 0.56 |
RMI2 |
RecQ mediated genome instability 2 |
17595 |
0.1 |
chr2_143910130_143910379 | 0.56 |
RP11-190J23.1 |
|
19487 |
0.22 |
chr1_65357847_65358013 | 0.55 |
JAK1 |
Janus kinase 1 |
74257 |
0.11 |
chr17_66234189_66234340 | 0.55 |
AMZ2 |
archaelysin family metallopeptidase 2 |
9451 |
0.16 |
chr1_151131578_151131836 | 0.55 |
SCNM1 |
sodium channel modifier 1 |
2567 |
0.12 |
chr1_206734639_206734815 | 0.54 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
4234 |
0.2 |
chr11_35353519_35353703 | 0.54 |
SLC1A2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
30536 |
0.17 |
chrX_70279615_70279837 | 0.54 |
SNX12 |
sorting nexin 12 |
8527 |
0.13 |
chr14_107130545_107130696 | 0.54 |
IGHV3-66 |
immunoglobulin heavy variable 3-66 |
940 |
0.18 |
chr8_134538342_134538795 | 0.54 |
ST3GAL1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
26942 |
0.25 |
chr1_5483788_5483939 | 0.54 |
ENSG00000264341 |
. |
140268 |
0.05 |
chr5_118618812_118619065 | 0.54 |
TNFAIP8 |
tumor necrosis factor, alpha-induced protein 8 |
14489 |
0.18 |
chr13_41165280_41165660 | 0.54 |
AL133318.1 |
Uncharacterized protein |
54147 |
0.14 |
chr9_135997202_135997382 | 0.54 |
RALGDS |
ral guanine nucleotide dissociation stimulator |
729 |
0.58 |
chr17_38635847_38636232 | 0.53 |
TNS4 |
tensin 4 |
1139 |
0.44 |
chr3_124720888_124721039 | 0.53 |
HEG1 |
heart development protein with EGF-like domains 1 |
99 |
0.97 |
chr13_74277884_74278165 | 0.53 |
KLF12 |
Kruppel-like factor 12 |
291162 |
0.01 |
chr2_106380015_106380293 | 0.53 |
NCK2 |
NCK adaptor protein 2 |
17966 |
0.27 |
chr9_127957633_127957872 | 0.53 |
RABEPK |
Rab9 effector protein with kelch motifs |
5069 |
0.17 |
chr5_39075421_39075578 | 0.53 |
RICTOR |
RPTOR independent companion of MTOR, complex 2 |
989 |
0.64 |
chr19_42144649_42144840 | 0.53 |
CEACAM4 |
carcinoembryonic antigen-related cell adhesion molecule 4 |
11302 |
0.14 |
chr9_124218171_124218322 | 0.53 |
ENSG00000240299 |
. |
38551 |
0.14 |
chr19_2561367_2561584 | 0.53 |
CTC-265F19.2 |
|
50385 |
0.09 |
chr15_64388627_64388778 | 0.53 |
SNX1 |
sorting nexin 1 |
477 |
0.73 |
chr16_30395134_30395286 | 0.53 |
SEPT1 |
septin 1 |
1039 |
0.28 |
chr7_8016148_8016299 | 0.52 |
AC006042.7 |
|
6689 |
0.19 |
chr2_222330421_222330740 | 0.52 |
EPHA4 |
EPH receptor A4 |
36700 |
0.2 |
chr2_87824602_87824793 | 0.52 |
RP11-1399P15.1 |
|
47144 |
0.18 |
chr5_172115051_172115202 | 0.52 |
CTB-79E8.2 |
|
9597 |
0.16 |
chr6_109771688_109771889 | 0.52 |
MICAL1 |
microtubule associated monooxygenase, calponin and LIM domain containing 1 |
802 |
0.48 |
chr16_89794033_89794184 | 0.52 |
ZNF276 |
zinc finger protein 276 |
6156 |
0.1 |
chr4_109028258_109028423 | 0.52 |
LEF1 |
lymphoid enhancer-binding factor 1 |
59117 |
0.12 |
chr1_111984468_111984619 | 0.52 |
RP11-552M11.4 |
|
557 |
0.57 |
chr22_40324230_40324381 | 0.52 |
GRAP2 |
GRB2-related adaptor protein 2 |
1664 |
0.35 |
chr20_39510251_39510483 | 0.51 |
ENSG00000238908 |
. |
27498 |
0.24 |
chr7_129424752_129424903 | 0.51 |
ENSG00000207691 |
. |
9973 |
0.15 |
chr22_50837864_50838126 | 0.51 |
ENSG00000238604 |
. |
746 |
0.51 |
chr1_67427377_67427614 | 0.51 |
MIER1 |
mesoderm induction early response 1, transcriptional regulator |
31569 |
0.16 |
chr21_46953100_46953305 | 0.51 |
SLC19A1 |
solute carrier family 19 (folate transporter), member 1 |
1327 |
0.48 |
chr11_121331388_121331838 | 0.50 |
RP11-730K11.1 |
|
7891 |
0.25 |
chr1_154926882_154927088 | 0.50 |
PBXIP1 |
pre-B-cell leukemia homeobox interacting protein 1 |
1595 |
0.18 |
chr16_88755979_88756211 | 0.50 |
SNAI3 |
snail family zinc finger 3 |
3194 |
0.1 |
chr8_37553639_37554052 | 0.49 |
ZNF703 |
zinc finger protein 703 |
576 |
0.66 |
chr19_42081963_42082129 | 0.49 |
CEACAM21 |
carcinoembryonic antigen-related cell adhesion molecule 21 |
541 |
0.74 |
chr16_28219632_28219882 | 0.49 |
XPO6 |
exportin 6 |
3040 |
0.24 |
chr12_133410838_133411057 | 0.49 |
ENSG00000252079 |
. |
1139 |
0.41 |
chr14_71112294_71112797 | 0.49 |
TTC9 |
tetratricopeptide repeat domain 9 |
4041 |
0.25 |
chr12_116538771_116538922 | 0.48 |
ENSG00000200665 |
. |
18471 |
0.21 |
chr19_42050710_42050898 | 0.48 |
CEACAM21 |
carcinoembryonic antigen-related cell adhesion molecule 21 |
5082 |
0.19 |
chr6_36172309_36172647 | 0.48 |
BRPF3 |
bromodomain and PHD finger containing, 3 |
287 |
0.89 |
chr17_38079214_38079389 | 0.48 |
ORMDL3 |
ORM1-like 3 (S. cerevisiae) |
1155 |
0.35 |
chr2_54794169_54794386 | 0.48 |
SPTBN1 |
spectrin, beta, non-erythrocytic 1 |
8746 |
0.19 |
chr12_123010667_123010875 | 0.48 |
RSRC2 |
arginine/serine-rich coiled-coil 2 |
716 |
0.5 |
chr16_30490311_30490462 | 0.48 |
RP11-297C4.3 |
|
2281 |
0.1 |
chr19_48827788_48827939 | 0.48 |
EMP3 |
epithelial membrane protein 3 |
719 |
0.53 |
chr16_49474926_49475274 | 0.48 |
C16orf78 |
chromosome 16 open reading frame 78 |
67366 |
0.13 |
chr13_22637652_22638073 | 0.48 |
ENSG00000244197 |
. |
273186 |
0.02 |
chr9_20228261_20228412 | 0.48 |
ENSG00000221744 |
. |
66666 |
0.13 |
chr9_135905332_135905511 | 0.48 |
GTF3C5 |
general transcription factor IIIC, polypeptide 5, 63kDa |
655 |
0.62 |
chr2_112183128_112183279 | 0.48 |
ENSG00000266139 |
. |
104535 |
0.08 |
chr9_92056751_92057221 | 0.48 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
5588 |
0.27 |
chr2_135425836_135426057 | 0.47 |
TMEM163 |
transmembrane protein 163 |
50624 |
0.17 |
chr2_204798430_204798581 | 0.47 |
ICOS |
inducible T-cell co-stimulator |
2966 |
0.36 |
chr1_226900136_226900391 | 0.47 |
ITPKB |
inositol-trisphosphate 3-kinase B |
24896 |
0.18 |
chr2_234318127_234318385 | 0.47 |
DGKD |
diacylglycerol kinase, delta 130kDa |
21456 |
0.15 |
chr1_154757692_154757865 | 0.47 |
KCNN3 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 |
74541 |
0.07 |
chr6_76316591_76316805 | 0.47 |
SENP6 |
SUMO1/sentrin specific peptidase 6 |
4935 |
0.19 |
chr19_18200434_18200728 | 0.47 |
IL12RB1 |
interleukin 12 receptor, beta 1 |
2768 |
0.19 |
chr4_38607318_38607597 | 0.47 |
RP11-617D20.1 |
|
18739 |
0.21 |
chr12_40589336_40589575 | 0.47 |
LRRK2 |
leucine-rich repeat kinase 2 |
1091 |
0.6 |
chr12_111608513_111608664 | 0.47 |
CUX2 |
cut-like homeobox 2 |
71338 |
0.1 |
chr10_72083599_72083820 | 0.47 |
NPFFR1 |
neuropeptide FF receptor 1 |
40277 |
0.14 |
chr9_126138722_126138873 | 0.47 |
CRB2 |
crumbs homolog 2 (Drosophila) |
7629 |
0.23 |
chr1_23945435_23945729 | 0.47 |
MDS2 |
myelodysplastic syndrome 2 translocation associated |
8242 |
0.19 |
chr19_9968157_9968686 | 0.47 |
OLFM2 |
olfactomedin 2 |
423 |
0.71 |
chr12_111166521_111166691 | 0.47 |
PPP1CC |
protein phosphatase 1, catalytic subunit, gamma isozyme |
4087 |
0.23 |
chr17_75879008_75879611 | 0.46 |
FLJ45079 |
|
650 |
0.77 |
chr14_60621220_60621381 | 0.46 |
DHRS7 |
dehydrogenase/reductase (SDR family) member 7 |
1408 |
0.46 |
chr10_114711627_114712035 | 0.46 |
RP11-57H14.2 |
|
197 |
0.91 |
chr2_198169561_198169772 | 0.46 |
ANKRD44-IT1 |
ANKRD44 intronic transcript 1 (non-protein coding) |
2423 |
0.25 |
chr8_19329786_19330179 | 0.46 |
CSGALNACT1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
129394 |
0.06 |
chr19_40336344_40336545 | 0.46 |
FBL |
fibrillarin |
525 |
0.75 |
chr15_101138173_101138360 | 0.45 |
LINS |
lines homolog (Drosophila) |
1125 |
0.41 |
chr19_19746136_19746287 | 0.45 |
GMIP |
GEM interacting protein |
2785 |
0.16 |
chr2_429739_429917 | 0.45 |
FAM150B |
family with sequence similarity 150, member B |
140977 |
0.04 |
chr14_91871423_91871574 | 0.45 |
CCDC88C |
coiled-coil domain containing 88C |
12192 |
0.23 |
chr22_20005369_20005520 | 0.44 |
TANGO2 |
transport and golgi organization 2 homolog (Drosophila) |
890 |
0.34 |
chr19_29700315_29700628 | 0.44 |
UQCRFS1 |
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
3977 |
0.3 |
chr15_91498636_91498821 | 0.44 |
AC068831.6 |
|
273 |
0.48 |
chr14_61844385_61844536 | 0.44 |
PRKCH |
protein kinase C, eta |
12952 |
0.23 |
chr1_145153893_145154044 | 0.44 |
ENSG00000201789 |
. |
4128 |
0.24 |
chrX_148603616_148603869 | 0.44 |
IDS |
iduronate 2-sulfatase |
1107 |
0.44 |
chr18_76394598_76394749 | 0.44 |
ENSG00000201723 |
. |
90485 |
0.1 |
chr17_47814021_47814341 | 0.44 |
FAM117A |
family with sequence similarity 117, member A |
12292 |
0.14 |
chr15_90479619_90479888 | 0.44 |
C15orf38 |
chromosome 15 open reading frame 38 |
23565 |
0.1 |
chr3_16355269_16355595 | 0.43 |
RP11-415F23.2 |
|
514 |
0.77 |
chr7_66395703_66395854 | 0.43 |
TMEM248 |
transmembrane protein 248 |
167 |
0.95 |
chr1_26697390_26697759 | 0.43 |
ZNF683 |
zinc finger protein 683 |
333 |
0.82 |
chr19_49179022_49179173 | 0.43 |
NTN5 |
netrin 5 |
2759 |
0.12 |
chr1_120665650_120665841 | 0.43 |
ENSG00000207149 |
. |
3817 |
0.3 |
chr18_61559637_61559788 | 0.43 |
SERPINB2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
1921 |
0.31 |
chr1_894146_894297 | 0.43 |
NOC2L |
nucleolar complex associated 2 homolog (S. cerevisiae) |
449 |
0.63 |
chr15_60830873_60831064 | 0.43 |
CTD-2501E16.2 |
|
8796 |
0.2 |
chr1_206755327_206755741 | 0.43 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
25041 |
0.13 |
chr15_53098421_53098572 | 0.43 |
ONECUT1 |
one cut homeobox 1 |
16287 |
0.27 |
chr1_155184602_155184753 | 0.43 |
RP11-263K19.6 |
|
1067 |
0.21 |
chr1_100821699_100821850 | 0.43 |
CDC14A |
cell division cycle 14A |
3269 |
0.24 |
chr3_48520196_48520441 | 0.42 |
SHISA5 |
shisa family member 5 |
5701 |
0.1 |
chr2_38580024_38580175 | 0.42 |
ATL2 |
atlastin GTPase 2 |
23267 |
0.25 |
chr3_171175083_171175417 | 0.42 |
TNIK |
TRAF2 and NCK interacting kinase |
2602 |
0.31 |
chr11_1892605_1892764 | 0.42 |
LSP1 |
lymphocyte-specific protein 1 |
568 |
0.59 |
chr5_54438198_54438349 | 0.42 |
GPX8 |
glutathione peroxidase 8 (putative) |
17673 |
0.11 |
chr1_169673656_169673937 | 0.42 |
SELL |
selectin L |
7043 |
0.2 |
chr17_62346863_62347014 | 0.42 |
TEX2 |
testis expressed 2 |
6277 |
0.23 |
chr14_99667002_99667153 | 0.42 |
AL162151.4 |
|
42324 |
0.16 |
chr6_108048768_108049144 | 0.42 |
SCML4 |
sex comb on midleg-like 4 (Drosophila) |
4643 |
0.33 |
chr5_57841897_57842048 | 0.42 |
CTD-2117L12.1 |
Uncharacterized protein |
12098 |
0.18 |
chr2_9984099_9984275 | 0.42 |
TAF1B |
TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa |
535 |
0.83 |
chr19_8258130_8258343 | 0.42 |
CERS4 |
ceramide synthase 4 |
13384 |
0.16 |
chr9_117668023_117668209 | 0.42 |
TNFSF8 |
tumor necrosis factor (ligand) superfamily, member 8 |
24581 |
0.23 |
chr4_154448725_154449000 | 0.42 |
KIAA0922 |
KIAA0922 |
28186 |
0.22 |
chr3_33049542_33050127 | 0.42 |
CCR4 |
chemokine (C-C motif) receptor 4 |
56768 |
0.12 |
chr6_135449440_135449615 | 0.41 |
HBS1L |
HBS1-like (S. cerevisiae) |
25333 |
0.18 |
chr14_23754755_23754960 | 0.41 |
HOMEZ |
homeobox and leucine zipper encoding |
469 |
0.61 |
chr17_66343908_66344364 | 0.41 |
ARSG |
arylsulfatase G |
56477 |
0.1 |
chr18_2634954_2635303 | 0.41 |
ENSG00000202224 |
. |
14039 |
0.13 |
chr18_3243897_3244048 | 0.41 |
MYL12A |
myosin, light chain 12A, regulatory, non-sarcomeric |
3507 |
0.19 |
chr1_144594079_144594458 | 0.41 |
RP11-640M9.2 |
|
20863 |
0.2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.1 | 0.6 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
0.1 | 0.7 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.1 | 0.3 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.1 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.4 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 0.3 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.1 | 0.4 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.6 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.4 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.9 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.1 | 0.2 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.1 | 0.2 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.1 | 0.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 0.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.2 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.1 | 0.2 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.3 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.1 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.4 | GO:0009304 | tRNA transcription(GO:0009304) |
0.1 | 0.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.2 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.1 | 0.2 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.1 | 0.2 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 1.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.1 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.5 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0002385 | innate immune response in mucosa(GO:0002227) mucosal immune response(GO:0002385) |
0.0 | 0.0 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.0 | 0.0 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.1 | GO:0051138 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.0 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.2 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.1 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.0 | 0.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.0 | 0.1 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.0 | 0.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.0 | GO:0015904 | tetracycline transport(GO:0015904) |
0.0 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 1.1 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0071503 | response to heparin(GO:0071503) |
0.0 | 0.1 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.0 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.0 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) |
0.0 | 0.9 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.2 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.0 | 0.3 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.0 | 0.1 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.0 | 0.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.0 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.2 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.0 | GO:0090286 | nuclear matrix organization(GO:0043578) cytoskeletal anchoring at nuclear membrane(GO:0090286) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.2 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.2 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.2 | GO:0033233 | regulation of protein sumoylation(GO:0033233) positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.1 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.6 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.1 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.0 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.0 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.1 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.3 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.1 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.0 | 0.7 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.0 | 0.0 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.0 | 0.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.1 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.0 | 0.1 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.0 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.0 | 0.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.1 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.2 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.1 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.4 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.0 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.1 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.0 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.3 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.1 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.1 | GO:0021779 | oligodendrocyte cell fate commitment(GO:0021779) |
0.0 | 0.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.0 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.0 | 0.1 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.0 | 0.1 | GO:1903393 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.0 | 0.0 | GO:0032747 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.0 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.0 | 0.4 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.9 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.1 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.1 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.0 | 0.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.0 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.1 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.0 | 0.1 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.0 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.1 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.0 | 0.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.1 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.0 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.0 | 0.0 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.0 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.0 | 0.2 | GO:0006906 | vesicle fusion(GO:0006906) |
0.0 | 0.0 | GO:0070932 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.0 | 0.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.0 | GO:2000318 | T-helper cell lineage commitment(GO:0002295) alpha-beta T cell lineage commitment(GO:0002363) CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) T-helper 17 type immune response(GO:0072538) T-helper 17 cell differentiation(GO:0072539) T-helper 17 cell lineage commitment(GO:0072540) regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 17 cell differentiation(GO:2000319) positive regulation of T-helper 17 cell differentiation(GO:2000321) regulation of T-helper 17 cell lineage commitment(GO:2000328) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.0 | 1.1 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.0 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.0 | GO:0016233 | telomere capping(GO:0016233) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:0060996 | dendritic spine development(GO:0060996) |
0.0 | 0.1 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 0.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.0 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.1 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.0 | 1.1 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.1 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.0 | GO:0097502 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.0 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.0 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.0 | 0.3 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) CENP-A containing nucleosome assembly(GO:0034080) DNA replication-independent nucleosome organization(GO:0034724) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.0 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.0 | GO:0031034 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.0 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.0 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.0 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.0 | 0.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.0 | GO:0048284 | organelle fusion(GO:0048284) |
0.0 | 0.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.1 | GO:0006560 | proline metabolic process(GO:0006560) |
0.0 | 0.2 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.0 | GO:0060251 | regulation of glial cell proliferation(GO:0060251) |
0.0 | 0.0 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.0 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.0 | GO:0060206 | estrous cycle phase(GO:0060206) |
0.0 | 0.0 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.0 | 0.1 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.1 | GO:0072506 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.0 | 0.2 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.0 | 0.0 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.0 | 0.0 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.0 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.0 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.0 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.0 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.0 | 0.0 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.1 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.0 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.0 | GO:0071883 | adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.0 | 0.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.0 | 0.2 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.0 | GO:0032898 | neurotrophin production(GO:0032898) |
0.0 | 0.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.0 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.2 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.3 | GO:0002429 | immune response-activating cell surface receptor signaling pathway(GO:0002429) |
0.0 | 0.0 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.0 | 0.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.0 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.0 | GO:0045359 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.0 | 0.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.0 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.5 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.0 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.0 | GO:0090026 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.2 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.0 | GO:1903579 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.0 | 0.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.0 | GO:0072678 | T cell chemotaxis(GO:0010818) regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) T cell migration(GO:0072678) regulation of lymphocyte chemotaxis(GO:1901623) regulation of lymphocyte migration(GO:2000401) positive regulation of lymphocyte migration(GO:2000403) regulation of T cell migration(GO:2000404) positive regulation of T cell migration(GO:2000406) |
0.0 | 0.0 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.0 | 0.3 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.1 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.0 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.0 | 0.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.1 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 0.0 | GO:0035751 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.0 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.0 | 0.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.1 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.1 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.0 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 0.0 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.0 | 0.0 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.2 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.0 | 0.1 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.0 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.1 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.0 | GO:0042441 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.0 | 0.0 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.0 | 0.1 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.2 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.0 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.0 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.1 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.6 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.3 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.1 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.4 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.0 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.3 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.2 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.4 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.0 | 0.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.1 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.2 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.0 | GO:0030313 | cell envelope(GO:0030313) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.0 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.1 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.0 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.0 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.2 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 0.7 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.3 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.1 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.0 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.0 | 0.1 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.0 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.3 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.2 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.3 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.0 | 0.0 | GO:0098573 | intrinsic component of mitochondrial inner membrane(GO:0031304) intrinsic component of mitochondrial membrane(GO:0098573) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.9 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 0.2 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.5 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.4 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.1 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 0.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.0 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.0 | 0.3 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 0.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0090568 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 0.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.3 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.3 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.1 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.2 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.0 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.0 | 0.5 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.0 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.5 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.1 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 1.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 1.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.0 | GO:0005035 | death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.1 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.0 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.3 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.3 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.3 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.1 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.0 | 0.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 1.1 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.0 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.0 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.2 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.0 | 0.1 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.1 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.0 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.0 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.0 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.0 | GO:0051379 | alpha2-adrenergic receptor activity(GO:0004938) epinephrine binding(GO:0051379) |
0.0 | 0.1 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.1 | GO:0080031 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.0 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.8 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.1 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 1.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.1 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.1 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 2.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 1.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 1.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.3 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.7 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.3 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.9 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.4 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 1.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.0 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.0 | 0.2 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 1.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 1.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME INNATE IMMUNE SYSTEM | Genes involved in Innate Immune System |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.1 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.0 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.2 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 1.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.7 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.0 | 0.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.0 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |